Richard Vander Heide, M.D., Ph.D., is a Professor in the Department of Pathology, where his clinical foci include cardiovascular and autopsy pathology and his research concerns myocardial cell injury and adaptation, especially ischemia/reperfusion injury; drug development for this type of heart muscle injury; and cell signaling. He earned both a doctorate in experimental pathological sciences and a medical degree from Northwestern University in Chicago, before completing a residency in anatomic pathology at Duke University. At Wayne State University Medical School in Detroit, he was Residency Program Director for five years and was thrice named the best pathology instructor by the sophomore medical student class. Prior to joining the LSU faculty in 2009, he was Chief of Pathology at the John D. Dingell VA Medical Center in Detroit. His cancer-related interests include the effects of chemotherapeutic agents on the heart and heart function, specifically in cases of adriamycin cardiotoxicity.

.

.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .